United States Adalimumab Market Report 2016

United States Adalimumab Market Report 2016

1 Adalimumab Overview

1.1 Product Overview and Scope of Adalimumab

1.2 Classification of Adalimumab

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Adalimumab

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 United States Market Size Sales (Value) and Revenue (Volume) of Adalimumab (2011-2021)

1.4.1 United States Adalimumab Sales and Growth Rate (2011-2021)

1.4.2 United States Adalimumab Revenue and Growth Rate (2011-2021)

2 United States Adalimumab Competition by Manufacturers

2.1 United States Adalimumab Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Adalimumab Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Adalimumab Average Price by Manufactures (2015 and 2016)

2.4 Adalimumab Market Competitive Situation and Trends

2.4.1 Adalimumab Market Concentration Rate

2.4.2 Adalimumab Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Adalimumab Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 United States Adalimumab Sales and Market Share by Type (2011-2016)

3.2 United States Adalimumab Revenue and Market Share by Type (2011-2016)

3.3 United States Adalimumab Price by Type (2011-2016)

3.4 United States Adalimumab Sales Growth Rate by Type (2011-2016)

4 United States Adalimumab Sales (Volume) by Application (2011-2016)

4.1 United States Adalimumab Sales and Market Share by Application (2011-2016)

4.2 United States Adalimumab Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 United States Adalimumab Manufacturers Profiles/Analysis

5.1 Janssen Biotech

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Adalimumab Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Janssen Biotech Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 GlaxoSmithKline

5.2.2 Adalimumab Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 GlaxoSmithKline Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Sanofi

5.3.2 Adalimumab Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Sanofi Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 MedImmune

5.4.2 Adalimumab Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 MedImmune Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 UCB

5.5.2 Adalimumab Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 UCB Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Novartis

5.6.2 Adalimumab Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Novartis Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Delenex Therapeutics

5.7.2 Adalimumab Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Delenex Therapeutics Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Ablynx

5.8.2 Adalimumab Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Ablynx Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 Sandoz

5.9.2 Adalimumab Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 Sandoz Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 Zydus Cadila

5.10.2 Adalimumab Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 Zydus Cadila Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

6 Adalimumab Manufacturing Cost Analysis

6.1 Adalimumab Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Adalimumab

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Adalimumab Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Adalimumab Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 United States Adalimumab Market Forecast (2016-2021)

10.1 United States Adalimumab Sales, Revenue Forecast (2016-2021)

10.2 United States Adalimumab Sales Forecast by Type (2016-2021)

10.3 United States Adalimumab Sales Forecast by Application (2016-2021)

10.4 Adalimumab Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Disclosure Section

Research Methodology

Data Source

Disclaimer

Figure Picture of Adalimumab

Table Classification of Adalimumab

Figure United States Sales Market Share of Adalimumab by Type in 2015

Table Application of Adalimumab

Figure United States Sales Market Share of Adalimumab by Application in 2015

Figure United States Adalimumab Sales and Growth Rate (2011-2021)

Figure United States Adalimumab Revenue and Growth Rate (2011-2021)

Table United States Adalimumab Sales of Key Manufacturers (2015 and 2016)

Table United States Adalimumab Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Adalimumab Sales Share by Manufacturers

Figure 2016 Adalimumab Sales Share by Manufacturers

Table United States Adalimumab Revenue by Manufacturers (2015 and 2016)

Table United States Adalimumab Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Adalimumab Revenue Share by Manufacturers

Table 2016 United States Adalimumab Revenue Share by Manufacturers

Table United States Market Adalimumab Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Adalimumab Average Price of Key Manufacturers in 2015

Figure Adalimumab Market Share of Top 3 Manufacturers

Figure Adalimumab Market Share of Top 5 Manufacturers

Table United States Adalimumab Sales by Type (2011-2016)

Table United States Adalimumab Sales Share by Type (2011-2016)

Figure United States Adalimumab Sales Market Share by Type in 2015

Table United States Adalimumab Revenue and Market Share by Type (2011-2016)

Table United States Adalimumab Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Adalimumab by Type (2011-2016)

Table United States Adalimumab Price by Type (2011-2016)

Figure United States Adalimumab Sales Growth Rate by Type (2011-2016)

Table United States Adalimumab Sales by Application (2011-2016)

Table United States Adalimumab Sales Market Share by Application (2011-2016)

Figure United States Adalimumab Sales Market Share by Application in 2015

Table United States Adalimumab Sales Growth Rate by Application (2011-2016)

Figure United States Adalimumab Sales Growth Rate by Application (2011-2016)

Table Janssen Biotech Basic Information List

Table Janssen Biotech Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Janssen Biotech Adalimumab Sales Market Share (2011-2016)

Table GlaxoSmithKline Basic Information List

Table GlaxoSmithKline Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)

Table GlaxoSmithKline Adalimumab Sales Market Share (2011-2016)

Table Sanofi Basic Information List

Table Sanofi Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)

Table Sanofi Adalimumab Sales Market Share (2011-2016)

Table MedImmune Basic Information List

Table MedImmune Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)

Table MedImmune Adalimumab Sales Market Share (2011-2016)

Table UCB Basic Information List

Table UCB Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)

Table UCB Adalimumab Sales Market Share (2011-2016)

Table Novartis Basic Information List

Table Novartis Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)

Table Novartis Adalimumab Sales Market Share (2011-2016)

Table Delenex Therapeutics Basic Information List

Table Delenex Therapeutics Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)

Table Delenex Therapeutics Adalimumab Sales Market Share (2011-2016)

Table Ablynx Basic Information List

Table Ablynx Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)

Table Ablynx Adalimumab Sales Market Share (2011-2016)

Table Sandoz Basic Information List

Table Sandoz Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)

Table Sandoz Adalimumab Sales Market Share (2011-2016)

Table Zydus Cadila Basic Information List

Table Zydus Cadila Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)

Table Zydus Cadila Adalimumab Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Adalimumab

Figure Manufacturing Process Analysis of Adalimumab

Figure Adalimumab Industrial Chain Analysis

Table Raw Materials Sources of Adalimumab Major Manufacturers in 2015

Table Major Buyers of Adalimumab

Table Distributors/Traders List

Figure United States Adalimumab Production and Growth Rate Forecast (2016-2021)

Figure United States Adalimumab Revenue and Growth Rate Forecast (2016-2021)

Table United States Adalimumab Production Forecast by Type (2016-2021)

Table United States Adalimumab Consumption Forecast by Application (2016-2021)